Cited 944 times in
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.